Withdrawn trial tested dietary supplement to fight COVID symptoms
NCT ID NCT05552625
Summary
This study aimed to test if a dietary supplement called TADIOS could help people with mild to moderate COVID-19 recover faster. It planned to give the supplement or a placebo (dummy pill) to 100 hospitalized patients for up to 10 days. The main goals were to see if it reduced symptoms like fever and cough, lowered body inflammation, and improved patients' sense of well-being.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chaitanya Hospital
Paravūr, Kerala, 683513, India
-
Gunjkar Multispeciality Hospital
Pune, Maharashtra, 4110019, India
-
Lakshmi Nursing Home
Kochi, Kerala, 683101, India
-
Oxycare Multispecialty Hospital
Pune, Maharashtra, 411033, India
-
Sparsh Superspeciality Hospital
Bangalore, Karnataka, 560022, India
-
Vagus Super Specialty Hospital
Bangalore, Karnataka, 560003, India
Conditions
Explore the condition pages connected to this study.